Markets Snapshot: 35 Major Stories About The Financial Markets Today
"U.S. equities held most of their gains on Wednesday as investors digested President Donald Trump's outline for tax reform, while earnings season continued.
Akebia Therapeutics Inc. (AKBA)
Market is closed
News
- First
- << Previous
- 21 - 28
Akebia Therapeutics Inc (AKBA) Sells Partial US Rights For Vadadustat To Otsuka
Akebia Therapeutics Inc (NASDAQ:AKBA) has surrendered 50% of U.S. commercialization rights to its oral anemia drug candidate vadadustat to Otsuka Pharmaceutical, a Japanese company.
Is Akebia Therapeutics Inc (AKBA) A Good Stock To Buy?
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research ...
Calculating The Impact Of Akebia Therapeutics Inc (AKBA)'s Pivotals
Akebia Therapeutics Inc (NASDAQ:AKBA) just gave word of the initiation of its pivotal trial in a second indication for its lead renal anemia candidate, Vadadustat.
13G Filing: Eagle Asset Management Inc Updates Akebia Therapeutics, Inc. (AKBA) Position
A new 13G filing has been submitted to the SEC by Eagle Asset Management, in relation to the investor's position in Akebia Therapeutics, Inc. (NASDAQ:AKBA), which stands at 12.91% of its common stock.
13D Filing: Kearny Venture Partners LP Files on Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc.
Akebia Therapeutics Inc (AKBA) Hedge Funds Are Snapping Up
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
Should You Follow Hedge Fund Sentiment Of Wednesday's Top 3 Healthcare Gainers?
As we have covered the top losers among healthcare stocks earlier today, which included three biotech companies, it's time to take a look at some companies that have been gaining ground.
- First
- << Previous
- 21 - 28
Billionaire Hedge Funds
